Global Lipid Panel Testing Market Growth (Status and Outlook) 2024-2030

Global Lipid Panel Testing Market Growth (Status and Outlook) 2024-2030

Lipid Panel Testing, also known as a lipid profile or cholesterol panel, is a blood test that measures various types of lipids in the bloodstream, including cholesterol and triglycerides. It is used to assess an individual's risk of heart disease and to monitor the effectiveness of lipid-lowering treatments.

The global Lipid Panel Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Lipid Panel Testing Industry Forecast” looks at past sales and reviews total world Lipid Panel Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Lipid Panel Testing sales for 2024 through 2030. With Lipid Panel Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Panel Testing industry.

This Insight Report provides a comprehensive analysis of the global Lipid Panel Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lipid Panel Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Panel Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Panel Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Panel Testing.

United States market for Lipid Panel Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Lipid Panel Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Lipid Panel Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Lipid Panel Testing players cover Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical and Abbott, F, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Panel Testing market by product type, application, key players and key regions and countries.

Segmentation by type
Devices
Kits
Services

Segmentation by application
Hospitals
Pathology Laboratories
Diagnostic Clinics
Ambulatory Surgical Center
Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nova Biomedical
Spark Diagnostics Pvt. Ltd.
Everlywell, Inc.
HORIBA Medical
Abbott, F
Hoffmann-La Roche Ltd.
SD Biosensor, INC.
Elitech Group
Randox Laboratories Ltd.
Diatron
Siemens Healthcare GmbH
Sinocare
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
myLAB Box
Awareness Technology, Inc.
Croda International Plc.
Eurofins Scientific
Boston Heart Diagnostics Corporation
PTS Diagnostics
ARUP Laboratories
Laboratory Corporation of America Holdings
EKF Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver.